8月 - 2025

Certified as a venture company originating from Osaka Metropolitan University

Thanks to the efforts of our medical advisor, Professor Shinya Fukumoto, our company has been certified as a venture company originating from Osaka Metropolitan University. Osaka Metropolitan University is the patent holder of ICS basic material patent No. 5725489, US 2011/0104292A1. https://www.omu.ac.jp/research/collaboration/result/venture/

Aug 9, 2025

Latest Articles

Premo Partner Co., Ltd. wins the top prize in the "MedTech Angels Season 5" acceleration program specializing in medical devices.

Selected for the MEDISO Acceleration Program Direct Flight "San Diego Biotech Week Program supported by KBIC"

At the 25th Annual Meeting of the Japanese Society for Regenerative Medicine, I gave an oral presentation on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemi...

At the 6th Annual Meeting of the Japanese Society of Foot Care and Podiatric Medicine, we presented on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemia (CLT...

Selected for JETRO's "J-StarX Biotech Accelerator Program"

LINK-J Pitch Contest "Changing Tomorrow": Special Jury Prize awarded in the Innovation Series showcasing advancements at the Kashiwanoha-Tsukuba Life Science Cluster.

Selected for the second round of research and development grants for fiscal year 2025 from the Mitsubishi UFJ Technology Development Foundation.

A paper detailing the clinical trial of a physician-initiated clinical study using injectable cell scaffold (ICS-001) for comprehensive angiogenesis therapy for severe chronic lower limb ischemia (...

Certified as a venture company originating from Hyogo College of Medicine.

Selected as a recipient company for the 13th term of the Small and Medium Enterprise Infrastructure Development Organization's acceleration program "FASTAR".